| 1 | jin lab computationalfunctional genomics | | | | | | | 1 | 0.64% |
| 2 | functionally and mechanistically characterizing | | | | | | | 1 | 0.64% |
| 3 | as sirna 3cchiprtqpcr western | | | | | | | 1 | 0.64% |
| 4 | such as sirna 3cchiprtqpcr | | | | | | | 1 | 0.64% |
| 5 | techniques such as sirna | | | | | | | 1 | 0.64% |
| 6 | and progression using novel | | | | | | | 1 | 0.64% |
| 7 | development and progression using | | | | | | | 1 | 0.64% |
| 8 | cancer development and progression | | | | | | | 1 | 0.64% |
| 9 | in cancer development and | | | | | | | 1 | 0.64% |
| 10 | marks in cancer development | | | | | | | 1 | 0.64% |
| 11 | epigenetic marks in cancer | | | | | | | 1 | 0.64% |
| 12 | characterizing the roles of | | | | | | | 1 | 0.64% |
| 13 | mechanistically characterizing the roles | | | | | | | 1 | 0.64% |
| 14 | and mechanistically characterizing the | | | | | | | 1 | 0.64% |
| 15 | hic rnaseq and mirnaseq | | | | | | | 1 | 0.64% |
| 16 | 3cchiprtqpcr western blotting 3dfish | | | | | | | 1 | 0.64% |
| 17 | tcc hic rnaseq and | | | | | | | 1 | 0.64% |
| 18 | dripseq tcc hic rnaseq | | | | | | | 1 | 0.64% |
| 19 | epicseq dripseq tcc hic | | | | | | | 1 | 0.64% |
| 20 | mbdcapseq epicseq dripseq tcc | | | | | | | 1 | 0.64% |
| 21 | chipseq mbdcapseq epicseq dripseq | | | | | | | 1 | 0.64% |
| 22 | lab computationalfunctional genomics and | | | | | | | 1 | 0.64% |
| 23 | ngs technologies such as | | | | | | | 1 | 0.64% |
| 24 | sequencing ngs technologies such | | | | | | | 1 | 0.64% |
| 25 | generation sequencing ngs technologies | | | | | | | 1 | 0.64% |
| 26 | next generation sequencing ngs | | | | | | | 1 | 0.64% |
| 27 | through next generation sequencing | | | | | | | 1 | 0.64% |
| 28 | data through next generation | | | | | | | 1 | 0.64% |
| 29 | from the various omics | | | | | | | 1 | 0.64% |
| 30 | sirna 3cchiprtqpcr western blotting | | | | | | | 1 | 0.64% |
| 31 | western blotting 3dfish and | | | | | | | 1 | 0.64% |
| 32 | chromatin interactions from the | | | | | | | 1 | 0.64% |
| 33 | tissues to identify epigeneticdriven | | | | | | | 1 | 0.64% |
| 34 | such as breast prostate | | | | | | | 1 | 0.64% |
| 35 | models such as breast | | | | | | | 1 | 0.64% |
| 36 | cancer models such as | | | | | | | 1 | 0.64% |
| 37 | various cancer models such | | | | | | | 1 | 0.64% |
| 38 | on various cancer models | | | | | | | 1 | 0.64% |
| 39 | working on various cancer | | | | | | | 1 | 0.64% |
| 40 | are working on various | | | | | | | 1 | 0.64% |